Mountainside, NJ, United States of America

Andrew S Thompson

Graduated from:

University of Cambridge (UK)
Stanford University (UK)

USPTO Granted Patents = 75 (Patent Applications = 22)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 4.4

ph-index = 17

Forward Citations = 1,104(Granted Patents)

Forward Citations (Not Self Cited) = 1,062(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Alameda, CA (US) (2011)
Commack, NY (US) (2020)
South Plainfield, NJ (US) (2016 - 2021)
Norwood, NY (US) (2017 - 2021)
Mountainside, NJ (US) (1989 - 2022)
San Francisco, CA (US) (2019 - 2022)
Portola Valley, CA (US) (2012 - 2024)

Company Filing History:

Proteus Digital Health, Inc.

patents

10 out of 172

Intra-cellular Therapies, Inc.

Sunesis Pharmaceuticals, Inc.

patents

8. 3 out of 20

Horizon Therapeutics, LLC

patents

9. 3 out of 845

Otsuka Pharmaceutical Company, Limited

patents

10. 3 out of 11

Elizabeth Arden, Inc.

patents

11. 2 out of 72

Io Therapeutics, Inc.

patents

12. 2 out of 5,444

University of Texas System

patents

13. 1 out of 250

Btg International Limited

patents

14. 1 out of 58

Onyx Pharmaceuticals, Inc.

patents

15. 1 out of 11

Medivation Prostate Therapeutics, Inc.

Brigham Young University

patents

19. 6 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...

75 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12139490 - Process for preparing 1-(4-fluorophenyl)-4-((6bR, 10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one (2024-11-12),

2. 11928614 - Patient customized therapeutic regimens (2024-03-12),

3. 11510169 - Systems and methods for implementing permissionless network consensus using blockchain (2022-11-22),

4. 11476952 - Pharma-informatics system (2022-10-18),

5. 11412383 - Systems and methods for providing and using a decentralized wireless network (2022-08-09),

6. 11407751 - Hydrochloric acid salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4′:4,5]pyrrolo[1,2,3-de]quinoxaline (2022-08-09),

7. 11399284 - Systems and methods for providing and using proof of coverage in a decentralized wireless network (2022-07-26),

8. 11217342 - Ingestible event marker data framework (2022-01-04),

9. 11066407 - Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof (2021-07-20),

10. 11038964 - Systems and methods for smart device networking (2021-06-15),

11. 11014870 - Procedure for the preparation of 4-phenyl butyrate and uses thereof (2021-05-25),

12. 10939405 - Systems and methods for implementing permissionless network consensus using blockchain (2021-03-02),

13. 10925977 - Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications (2021-02-23),

14. 10919835 - Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids (2021-02-16),

15. 10814013 - Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications (2020-10-27),

As an AI assistant at idiyas.com, I've compiled an article on the renowned inventor Andrew S Thompson based on the provided data. Here is the structured content for your reference:

Title: Unveiling the Inventive Journey of Andrew S Thompson

Introduction:

Andrew S Thompson, a distinguished inventor hailing from Mountainside, NJ (US), has made significant contributions to the world of innovation with an impressive portfolio of 53 patents.

Latest Patents:

Among his latest patents is a groundbreaking invention titled "Systems and Methods for Implementing Permissionless Network Consensus Using Blockchain." This innovation introduces a novel approach characterized by various attributes such as decentralization, byzantine fault tolerance, and censor-resistant transactions, revolutionizing the blockchain network landscape.

He has also patented the "Hydrochloric Acid Salt of (6bR,10aS)-3-methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline," showcasing his versatility in developing methods for preparing substituted heterocycle fused gamma-carbolines and their intermediates.

Career Highlights:

Andrew S Thompson has notably been associated with esteemed companies such as Merck & Company, Inc. and Intra-Cellular Therapies, Inc., where his inventive spirit flourished, leading to groundbreaking advancements in the field.

Collaborations:

Throughout his illustrious career, Andrew collaborated closely with accomplished individuals like John Charles Tomesch and Peng Li, fostering an environment of innovation and knowledge exchange that propelled the development of cutting-edge technologies.

Conclusion:

Andrew S Thompson's remarkable journey as an inventor exemplifies a relentless pursuit of innovation, with his patents and collaborations standing as a testament to his invaluable contributions to the world of technology and beyond.

This article sheds light on the extraordinary innovations and inventive prowess of Andrew S Thompson, showcasing his profound impact on the realm of patents and inventions.

This text is generated by artificial intelligence and may not be accurate.